000 01149 a2200313 4500
005 20250513225758.0
264 0 _c20010125
008 200101s 0 0 eng d
022 _a0924-8579
024 7 _a10.1016/s0924-8579(00)00299-5
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aLivermore, D M
245 0 0 _aAntibiotic resistance in staphylococci.
_h[electronic resource]
260 _bInternational journal of antimicrobial agents
_cNov 2000
300 _aS3-10 p.
_bdigital
500 _aPublication Type: Journal Article; Review
650 0 4 _aAnti-Bacterial Agents
_xtherapeutic use
650 0 4 _aCoagulase
_xdeficiency
650 0 4 _aDrug Design
650 0 4 _aGlycopeptides
650 0 4 _aHumans
650 0 4 _aMethicillin Resistance
_xgenetics
650 0 4 _aPenicillinase
_xmetabolism
650 0 4 _aPenicillins
_xmetabolism
650 0 4 _aStaphylococcal Infections
_xdrug therapy
650 0 4 _aStaphylococcus aureus
_xdrug effects
773 0 _tInternational journal of antimicrobial agents
_gvol. 16 Suppl 1
_gp. S3-10
856 4 0 _uhttps://doi.org/10.1016/s0924-8579(00)00299-5
_zAvailable from publisher's website
999 _c11077481
_d11077481